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Purpose: The goal of this study was to validate the ultrasonography (US) and cytopathological 
features that are used in the diagnosis of the follicular variant of papillary thyroid carcinoma 
(FVPTC) and to characterize the role of BRAFV600E mutation analysis in the diagnosis of FVPTC. 
Methods: From May 2012 to February 2014, 40 thyroid nodules from 40 patients (mean age, 
56.2 years; range, 26 to 81 years) diagnosed with FVPTC were included in this study. The US 
features of the nodules were analyzed and the nodules were classified as probably benign or 
suspicious for malignancy. Twenty-three thyroid nodules (57.5%) underwent BRAFV600E mutation 
analysis. Clinical information and histopathologic results were obtained by reviewing the medical 
records of the patients.
Results: Thirty nodules (75.0%) were classified as suspicious for malignancy, while 10 (25.0%) 
were classified as probably benign. Seven of the eight nodules (87.5%) with atypia of 
undetermined significance/follicular lesion of undetermined significance (AUS/FLUS) cytology 
showed suspicious US features, while one of the two nodules (50.0%) with follicular neoplasm 
cytology presented suspicious US features. Five of the 23 nodules (21.7%) that underwent 
BRAFV600E mutation analysis had positive results, all of which were diagnosed as suspicious for 
malignancy or malignant based on cytology. None of the nodules with benign, AUS/FLUS, or 
follicular neoplasm cytology were positive for the BRAFV600E mutation.
Conclusion: US features allow nodules to be classified as suspicious for malignancy, and the 
presence of suspicious US features in nodules with ambiguous cytology may aid in the diagnosis 
of FVPTC. BRAFV600E mutation analysis is of limited value in the diagnosis of FVPTC. 
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Introduction
Papillary thyroid carcinoma (PTC) is the most common malignancy of the thyroid gland [1,2], 
and numerous variants of PTC have been reported with distinct histopathological features [3]. 
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Conventional or classical PTC is the most frequent type, while the 
follicular variant of papillary thyroid carcinoma (FVPTC) is the second 
most common variant; these variants comprise approximately 55%-
66% and 11.8%-31.6% of well differentiated thyroid carcinomas, 
respectively [1-5]. Cytologically, FVPTC contains cells that show the 
nuclear features of PTC, such as ground glass nuclei, nuclear grooves, 
and overlapping nuclei with or without nuclear inclusions [2,6], with 
a predominantly follicular growth pattern [4,7]. Although FVPTC 
has been reported to have a lower rate of lymph node metastasis 
and extrathyroidal extension-than classical PTC [3,7,8], but a higher 
rate of lung and bone metastasis [2,9], it is generally accepted that 
the clinical behavior of FVPTC resembles that of PTC, with similar 
patient outcomes [3,4,8,10,11]. Since the prognosis and the long-
term survival outcomes of patients with FVPTC are similar to those 
of patients with classical PTC, the same treatment strategies are 
currently applied to this variant form of thyroid carcinoma [3-5,11]. 
Many studies have evaluated the clinicopathological features and 
long-term outcomes of FVPTC alone or in comparison with classical 
PTC [3,4,6-8,10,11], whereas few studies have evaluated the 
ultrasonography (US) features of FVPTC [2,9]. Moreover, in light of 
the excellent sensitivity of BRAFV600E mutation analysis for detecting 
PTC, several recent studies have evaluated the role of BRAFV600E 
as a prognostic factor for FVPTC [1,12,13]. However, few studies 
have assessed correlations between US features and the cytological 
results of US-guided fine needle aspiration (US-FNA) in nodules 
diagnosed as FVPTC. In this study, we evaluated the preoperative 
US features, cytopathological characteristics, and BRAFV600E mutation 
analysis results in thyroid nodules diagnosed as FVPTC to determine 
whether any of those parameters are useful in predicting the 
diagnosis of FVPTC. 
Materials and Methods
This retrospective study was approved by the Institutional Review 
Board of Severance Hospital, Seoul, Korea. Neither patient approval 
nor informed consent was required for the review of medical records 
or images. Written informed consent was obtained from all patients 
before US-FNA and before all surgical procedures.
Patients 
From May 2012 to February 2014, 5,128 patients with 5,967 
thyroid nodules underwent US-FNA at our institution. Among them, 
40 thyroid nodules (0.7%) from 40 patients were histologically 
diagnosed as FVPTC after surgical excision. The mean age of the 
patients was 56.2 years (range, 26 to 81 years). Six (15.0%) were 
men and 34 (85.0%) were women. Of the 40 patients, 17 (42.5%) 
underwent lobectomy, while the remaining 23 (57.5%) underwent 
total thyroidectomy. Clinical information and histopathologic results 
were obtained by reviewing the medical records of the patients. 
US, US-FNA, and BRAFV600E Mutation Analysis
US was performed using a 5-12-MHz linear array transducer (iU22; 
Philips Medical Systems, Bothell, WA, USA). Compound imaging 
was used to obtain all images. Real-time US and subsequent US-
FNA were performed by one of seven board-certified radiologists 
(four faculty, three fellows) with 1-15 years of experience in thyroid 
imaging. US-FNA was performed on thyroid nodules showing 
suspicious US features or on the largest mass when none of the 
multiple thyroid nodules observed showed any suspicious US 
features.
The US features of each thyroid nodule were described according 
to the following categories: internal components, echogenicity, 
margin, calcifications, and shape [14]. Based on their internal 
components, nodules were classified as solid, predominantly 
solid (solid contents comprising more than 50% of the nodule), 
or predominantly cystic (solid contents comprising less than 50% 
of the nodule). Based on echogenicity, nodules were classified 
as hyperechoic or isoechoic (nodules showing hyperechogenicity 
or isoechogenicity when compared to the surrounding thyroid 
parenchyma), hypoechoic (nodules showing hypoechogenicity 
compared to the surrounding thyroid parenchyma), and markedly 
hypoechogenic (nodules showing hypoechogenicity compared 
to the adjacent strap muscle). The margins were classified as 
circumscribed or non-circumscribed (i.e., microlobulated or irregular 
margins). Based on the presence of calcifications, nodules were 
classified as having no calcifications, microcalcifications or mixed 
calcifications, or macrocalcifications including eggshell calcifications. 
The shape was classified as parallel or non-parallel (greater in the 
anteroposterior dimension than the transverse dimension, or ‘taller 
than wide’). Of these features, the US features considered indicative 
of malignancy were marked hypoechogenicity, non-circumscribed 
margins, microcalcifications or mixed calcifications, and a non-
parallel shape, based on previously established criteria [14]. The final 
assessment of the thyroid nodules was ‘probably benign’ when none 
of the suspicious US features described above were present, and as 
‘suspicious for malignancy’ when one or more of the suspicious US 
features were present.  
US-FNA was performed at least twice from each thyroid nodule 
using a 23-gauge needle attached to a 2-mL disposable syringe 
without an aspirator. Local anesthesia was not routinely applied. The 
aspirated material was expelled onto glass slides and immediately 
placed in 95% ethanol for Papanicolaou staining. The remaining 
material in the syringe was rinsed in saline for cell block processing. 
The cytopathologists were not present during the procedures, and 
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additional staining was performed on a case-by-case basis at the 
request of the cytopathologists. One of the seven cytopathologists 
specializing in thyroid pathology interpreted the cytology slides. 
During the period of the study, cytology reports involving US-FNA 
of the thyroid classified nodules according to the six categories in 
the Bethesda System for Reporting Cytopathology: non-diagnostic, 
benign, atypia of undetermined significance/follicular lesion of 
undetermined significance (AUS/FLUS), follicular neoplasm or 
suspicious for follicular neoplasm, suspicious for malignancy, and 
malignancy [15].   
During the US-FNA procedures, aspiration was performed once 
more for BRAFV600E mutation analysis if requested by the referring 
physicians. Of the 40 thyroid nodules included in this study, 23 
(57.5%) underwent BRAFV600E mutation analysis. The aspirated 
material was rinsed in 1 mL of normal saline, which was sent for 
BRAFV600E mutation analysis. Real-time polymerase chain reaction 
was used for detecting the BRAFV600E mutation during the study 
period at our institution [16]. 
Two of the 40 thyroid nodules underwent US-guided core needle 
biopsy due to repeated inconclusive cytology results. This procedure 
was performed using the freehand technique with a spring-activated 
18-gauge Tru-Cut-type needle (Acecut, TSK Laboratory, Tochigi, 
Japan). At least three biopsy cores were obtained, and the specimen 
was fixed in formalin solution and sent to the pathology department. 
Results
The size of the 40 thyroid nodules confirmed as FVPTC ranged 
from 4 to 53 mm (mean, 12.6±12.2 mm). Four nodules (10.0%) 
were palpable, while the remaining 36 (90.0%) were incidentally 
detected. Table 1 summarizes the clinical and pathological features 
of the 40 patients included in this study. Twenty-five nodules 
(62.5%) were encapsulated, while 15 (37.5%) were pathologically 
determined to be infiltrative. Six patients (15.0%) had multifocal 
lesions, and the remaining 34 (85.0%) had single lesions. Central or 
lateral cervical lymph node metastases were found in seven patients 
(17.5%) and two patients (5.0%), respectively. 
Table 2 summarizes the US features of the 40 thyroid nodules 
diagnosed as FVPTC in this study. The common US features observed 
among the 40 thyroid nodules were as follows: solid composition 
(92.5%), hypoechogenicity (62.5%), microlobulated margins 
(55.0%), no calcifications (37.5%), and a parallel shape (67.5%). 
Thirty nodules (75.0%) were classified as suspicious for malignancy, 
while 10 (25.0%) were classified as probably benign. 
Table 3 shows the correlations of cytological characteristics with 
US features and the BRAFV600E mutation analysis results of the 
40 FVPTC nodules. Of the 40 thyroid nodules, the preoperative 
cytology results were as follows: benign findings were observed 
in one nodule (2.5%) (Fig. 1), AUS/FLUS findings in eight nodules 
(20.0%) (Fig. 2), follicular neoplasm or suspicious for follicular 
neoplasm findings in two nodules (5.0%), a finding of suspicious for 
malignancy in 16 nodules (40.0%), and malignancy in 13 nodules 
(32.5%). Two nodules underwent US-guided core needle biopsy; 
both showed non-confirmative results, suggesting the possibility 
of follicular proliferative lesions. Ten nodules were assessed as 
probably benign, the cytology results were suspicious for malignancy 
or malignant in seven (70.0%), follicular neoplasm or suspicious 
for follicular neoplasm findings were observed in one nodule 
(10.0%), AUS/FLUS findings in one nodule (10.0%), and benign 
findings in one nodule (10.0%). Seven nodules (87.5%) with AUS/
Table 1. Clinical and pathological features the follicular variant 
of papillary thyroid carcinoma, based on samples of 40 nodules 
from 40 patients 
Characteristic No. (%)
Age (yr) 56.2±13.3 
    ≤45 10 (25.0)
    >45 30 (75.0)
Sex
    Female 34 (85.0)
    Male 6 (15.0)
Family history
    Absent 35 (87.5)
    Present 5 (12.5)
Tumor size (cm) 1.26±1.22
    <2 31 (77.5)
    2-4 6 (15.0)
    >4 3 (7.5)
Histologic subtype
    Encapsulated 25 (62.5)
    Infiltrative 15 (37.5)
Extrathyroid extension
    Absent 34 (85.0)
    Present 6 (15.0)
Multicentricity 
    Absent 34 (85.0)
    Present 6 (15.0)
Central lymph node metastasis
    Absent 33 (82.5)
    Present 7 (17.5)
Lateral lymph node metastasis
    Absent 38 (95.0)
    Present 2 (5.0)
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FLUS findings, one (50.0%) with a finding of follicular neoplasm 
or suspicious for follicular neoplasm, and 12 (75.0%) that were 
found to be suspicious for malignancy had suspicious US features. 
Five of the 23 nodules (21.7%) that underwent BRAFV600E mutation 
analysis had positive results, and all were diagnosed as suspicious 
for malignancy or malignant. None of the nodules with benign, AUS/
FLUS, or follicular neoplasm cytology were positive for the BRAFV600E 
mutation.
Discussion
FVPTC has been reported to have a relatively benign appearance 
compared to the typical US features seen in the classical variant 
of PTC [2,9]. The common US features of FVPTC observed in our 
study were a solid composition, hypoechogenicity, microlobulated 
margins, no calcifications, and a parallel shape, corresponding to the 
results of previous studies [2,9]. Each of these individual features 
is either a typically benign feature or is consistent with but not 
strongly suggestive of malignancy. Interestingly, although the most 
common US features of FVPTC in our study and in previous reports 
were typically benign, 75.0% (30 of 40 nodules) had more than one 
suspicious US feature. This observation indicates the importance of 
US features in predicting malignancy in thyroid nodules, which can 
be used as a guideline for patient management according to US-
FNA cytology results.  
US-FNA is considered the gold standard in the diagnosis of 
thyroid nodules, showing a high sensitivity of 83%-98% [8,12,14] 
and enabling benign nodules suitable for conservative follow-up 
to be differentiated from malignant nodules that require surgical 
intervention. However, US-FNA has limitations in the accurate 
diagnosis of FVPTC. The presence of a follicular arrangement of 
tumor cells is the cytological hallmark of FVPTC, and the presence 
of high cellularity, follicles and syncytial clusters, nuclear features of 
grooves, and enlarged nuclei with fine chromatin has been reported 
helpful in diagnosing FVPTC [3,17]. However, the characteristic 
cytological features described above are not always apparent, since 
these features may be focal or localized and not included during 
sampling procedures [3,16]. Moreover, it is difficult to distinguish 
between various follicular lesions of the thyroid, including benign 
adenomatous nodules, and follicular carcinomas based on 
cytological features alone [18]. The sensitivity of US-FNA cytology 
for the diagnosis of FVPTC has been reported to be lower than for 
Table 3. Correlations of cytological characteristics with ultrasonography (US) features and the results of BRAFV600E mutation analysis in 
40 nodules diagnosed as the follicular variant of papillary thyroid carcinoma, drawn from 40 patients 
Cytologya) US feature BRAFb)
Probably benign Suspicious for malignancy PPV (%) Total Negative Positive PPV (%) Total
Benign 1 (10.0) 00 (40.0) 0.0 1 (2.5) 1 (5.6) 0 0.0 1 (4.3)
AUS/FLUS 1 (10.0) 7 (23.3) 87.5 8 (20.0) 6 (33.3) 0 0.0 6 (26.1)
FN 1 (10.0) 1 (3.3) 50.0 2 (5.0) 0 0 0.0 00 (40.0)
SUSP 4 (40.0) 12 (40.0) 75.0 16 (40.0) 8 (44.4) 2 (40.0) 20.0 10 (43.5)
Malignancy 3 (30.0) 10 (33.3) 76.9 13 (32.5) 3 (16.7) 3 (60.0) 50.0 6 (26.1)
Values are presented as number (%) unless otherwise indicated.
PPV, positive predictive value for US finding or BRAFV600E mutation result; AUS/FLUS, atypia of undetermined significance/follicular lesion of undetermined 
significance; FN, follicular neoplasm or suspicious for follicular neoplasm; SUSP, suspicious for malignancy. 
a)According to the Bethesda System for Reporting Thyroid Cytopathology. b)23 nodules that underwent BRAFV600E mutation analysis were included. 
Table 2. Ultrasonography (US) features of the follicular variant 
of papillary thyroid carcinoma, based on 40 nodules from 40 
patients 
US feature No. (%)
Composition Solid 37 (92.5)
Predominantly solid 3 (7.5)
Echogenicity Hyperechoic to isoechoic 9 (22.5)
Hypoechogenicity 25 (62.5)
Markedly hypoechogenicity 6 (15.0)
Margin Well defined 14 (35.0)
Microlobulated 22 (55.0)
Irregular 4 (10.0)
Calcifications Microcalcifications and mixed 
calcifications 
13 (32.5)
Macrocalcifications and eggshell 
calcifications
12 (30.0)
Negative 15 (37.5)
Shape Parallel 27 (67.5)
Non-parallel 13 (32.5)
Parenchymal 
echogenicity
Homogeneous 28 (70.0)
Heterogeneous 12 (30.0)
Final assessment Probably benign 10 (25.0)   
Suspicious for malignancy 30 (75.0)
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the diagnosis of classical PTC [2,15]. Moreover, more suspicious 
cytological results are reported than malignant cytological results 
[2,3,19]. Our results follow this pattern; approximately 40.0% of the 
thyroid nodules had suspicious cytology results, compared to 32.5% 
with malignant cytology results. Seven of the eight nodules (87.5%) 
with AUS/FLUS results, one of the two nodules (50.0%) with a result 
of follicular neoplasm or suspicious for follicular neoplasm, and 12 
of the 16 nodules (75.0%) found to be suspicious for malignancy 
showed suspicious US features. Based on these findings, we suggest 
that US features may help in the accurate diagnosis of FVPTC in 
thyroid nodules showing ambiguous cytology results by correctly 
guiding clinicians towards further diagnostic procedures or surgery. 
Considering the difficulties involved in the definitive diagnosis 
of FVPTC based on cytological features alone, several reports have 
applied molecular studies including BRAFV600E mutation analysis to 
the diagnosis of FVPTC [1,12] in mutated lesions that already have 
suspicious or malignant cytology results [16]. Our results correspond 
to those of previous studies; five of the 23 nodules that underwent 
A B
Fig. 1. An incidentally detected thyroid mass in a 32-year-old woman. 
A, B. Ultrasonography (A, transverse; B, longitudinal) shows a 4.3-cm well-defined, predominantly solid mass with isoechoic features, a 
parallel shape, and no calcifications in the left thyroid. The final assessment of this thyroid mass was probably benign. C. Ultrasonography-
guided fine needle aspiration cytology shows (H&E, ×400) sheets of follicular cells without significant atypia, and the results of BRAFV600E 
mutation analysis were negative. Diagnostic lobectomy was performed due to the large size of the mass, and follicular variant of papillary 
thyroid carcinoma was confirmed on pathology. D. Microscopic images of the tumor (H&E, ×400) shows neoplastic follicles containing 
eosinophilic colloid, lined by cells with irregular nuclei that show nuclear grooves (arrow) and suspicious pseudoinclusion (arrowhead). 
C D
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known to be associated with a lower rate of the BRAFV600E mutation 
than classical PTC [20]. Moreover, several reports have shown a high 
frequency of RAS mutations in FVPTC [21], which may be useful in 
the preoperative diagnosis of FVPTC, although further research is 
required to reveal which molecular marker or markers are specific 
for FVPTC. 
This study has some limitations. First, this was a retrospective 
study of lesions diagnosed as FVPTC after surgery, meaning that 
BRAFV600E mutation analysis were positive for the mutation, of 
which two had suspicious and three had malignant cytology 
results. None of the nodules with benign, AUS/FLUS, or follicular 
neoplasm cytology results showed positive results in BRAFV600E 
mutation analysis. Therefore, we suggest that BRAFV600E mutation 
analysis is of limited value for providing additional information in 
the differential diagnosis of FVPTC. Debate continues regarding the 
role of BRAFV600E mutations in the diagnosis of FVPTC, as FVPTC is 
A B
Fig. 2. An incidentally detected thyroid mass in a 62-year-old woman. 
A, B. Ultrasonography (A, transverse; B, longitudinal) shows a 2.3-cm hypoechoic solid mass with microlobulated margins, macrocalcifications, 
and a parallel shape in the left thyroid. The final assessment of this thyroid mass was suspicious for malignancy. C. Ultrasonography-guided 
fine needle aspiration (US-FNA) cytology (H&E, ×100) demonstrates a low cellular aspirate composed of microfollicles and scattered isolated 
cells, and the results BRAFV600E mutation analysis were negative. The patient underwent surgery due to the repeated presence of atypia of 
undetermined significance/follicular lesion of undetermined significance results on follow-up US-FNA, and this mass was confirmed as the 
follicular variant of papillary thyroid carcinoma on surgery. D. Microscopic images of the tumor (H&E, ×400) shows neoplastic follicles of 
variable size and shape, with lines near the cells containing eosinophilic colloid, lined by cells with irregular nuclei that show prominent 
nucleoli, nuclear grooves (arrows) and suspicious pseudoinclusion (arrowhead). 
C D
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selection bias may have occurred. Larger prospective studies are 
anticipated in the future to validate our results. Second, seven 
cytopathologists were involved in the cytological slide review. 
Considerable interobserver variability exists in the diagnosis of 
FVPTC based on histology [12], but this issue was not considered 
in our study. Similarly, seven radiologists with different levels of 
experience in thyroid imaging reviewed the US images, meaning 
that interobserver variability may have affected those results. Fourth, 
only a limited number of nodules underwent BRAFV600E mutation 
analysis and core needle biopsy in this study. Further research 
involving a large number of cases will be required to conclusively 
establish the role of BRAFV600E mutation analysis and US-guided core 
needle biopsy in the diagnosis of FVPTC.
In conclusion, the US features of FVPTC have a relatively benign 
appearance, but most were ultimately classified as suspicious for 
malignancy. The presence of suspicious US features in nodules with 
ambiguous cytology may assist the accurate diagnosis of FVPTC. 
BRAFV600E mutation analysis is of limited value in the diagnosis of 
FVPTC, pending further validation studies. 
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